Skip to main content
Clinical Trials/NCT02067351
NCT02067351CompletedPhase 2

Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy

Mayo Clinic1 site in 1 country6 target enrollmentStarted: April 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
6
Locations
1
Primary Endpoint
Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)

Study Overview

Brief Summary

There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
20 Years to 75 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Women 20-75 years old
  • •Diagnosed with breast cancer
  • •Scheduled to begin chemotherapy at Mayo Clinic Rochester

Exclusion Criteria

  • •Practicing mindfulness

Arms & Interventions

Mindfulness Intervention

Experimental

Mindfulness intervention

Intervention: Mindfulness (Behavioral)

Outcomes

Primary Outcomes

Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)

Time Frame: While receiving chemotherapy (usually 4-5 months)

Secondary Outcomes

  • Stress - measured by the Perceived Stress Scale - statistically and clinically significant reductions in stress(7-8 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniela L. Stan, M.D

Daniela Stan, MD

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials